@heavyphil I have had access to doctors with extensive experience...that makes a difference when being treated. Additionally, it has been published and available in video presentations that most TULSA failures occurred in patients who had a calcification within the prostate. This obstacle has the potential to disrupt treatment or deflect treatment within the prostate leaving some cancer behind. This is something that should be checked prior to treatment.

I agree with your thoughts...it may have been experience of the doctor...or an unknown factor. Was this patient required to send his biopsy out for genomic testing? Did he have a pre-treatment PSMA PET scan? Did he have a post treatment PSMA PET scan or a biopsy to verify that they determined was a Biochemical recurrence (BCR)? Cut and Paste - With prostate cancer is a rising PSA level after initial curative treatment (surgery or radiation), can occur in roughly one-third of patients.

With that said, with TULSA...a patient is still going to generate PSA. I can't imagine going on ADT without additional verification (PSMA PET, a Biopsy and an MRI) that there is really cancer there. In fact, you can have bounces in your PSA since your can still have an inflamed prostate. If you can find the link to this individual, I'd be curious to learn what went into the decision making process to start this guy on ADT. Was this guy's doctor doing prostate density calculations.

If they failed to do a pre-treatment PSMA PET scan, cancer could have easily already have spread beyond the prostate and TULSA has absolutely no way of treating metastatic disease. The pre-treatment PSMA PET and and a scan for any calcification are critical steps that can impact the success of the TULSA treatment.

In closing, I will always be worried that my cancer will return. But, I would have been worried about that regardless of the procedure that I selected. Everyone must make their own choice and be comfortable with whatever that might be.